ZYUS Life Sciences Corporation (ZYUS:TSXV) closed at $0.350 on October 26, 2026, down 30.00% on the day. The stock trades 53.3% below its 52-week high of $0.750 and 16.7% above its 52-week low of $0.300. Over the past year, it lost 49.3%. ZYUS Life Sciences Corporation is part of the Health Care sector.
In 252 trading sessions since October 24, 2025, ZYUS closed higher on 26 days (10%). Its best day was September 15, 2026 (+66.67%) and its worst was October 26, 2026 (-30.00%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 6 times.
ZYUS is a Canadian-based life sciences company focused on the global development and commercialization of cannabinoid-based pharmaceutical drug product candidates and innovative exempt market therapeutics. Through clinical research, ZYUS is committed to furthering the understanding of cannabinoids with the clinical development of its pharmaceutical drug product candidates and intellectual property activities to protect its novel formulations. Additionally, ZYUS is dedicated to delivering high quality, cGMP / EU GMP-compliant cannabinoid products to patients through the exempt global medical market. The ZYUS vision is to elevate cannabinoid-based therapeutics as a standard of care and expand the potential of protein-based formulations in pursuit of a transformational impact on patients' lives around the world.
Find more stocks like ZYUS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.